Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
ANAPTYSBIO, INC (ANAB) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/10/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Anaptys Announces Positive Top-Line Phase 3 Clinical Trial Results of Imsidolimab"
08/07/2023 8-K Quarterly results
Docs: "AnaptysBio Announces Second Quarter 2023 Financial Results and Provides Business Update"
06/15/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
05/11/2023 8-K Quarterly results
Docs: "AnaptysBio Announces First Quarter 2023 Financial Results and Provides Pipeline Update"
04/06/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
03/01/2023 8-K Quarterly results
Docs: "AnaptysBio Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update"
02/10/2023 8-K Quarterly results
01/05/2023 8-K Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits  I...
Docs: "AnaptysBio Announces Portfolio Update Across Best-in-Class Immune Cell Modulating Antibodies",
"Corporate Overview January 2022 Nasdaq: ANAB"
11/08/2022 8-K Quarterly results
09/12/2022 8-K Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits  Inte...
Docs: "Corporate Overview September 2022 Nasdaq: ANAB"
08/31/2022 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "AnaptysBio Reports HARP Phase 2 Top-Line Data of Imsidolimab in Moderate-to-Severe Hidradenitis Suppurativa"
08/08/2022 8-K Quarterly results
06/24/2022 8-K Quarterly results
05/04/2022 8-K Quarterly results
04/29/2022 8-K Quarterly results
04/27/2022 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "AnaptysBio Announces Positive ANB032 Top-Line Phase 1 Data and Provides Pipeline Updates"
03/21/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
03/14/2022 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "AnaptysBio Reports Imsidolimab ACORN Phase 2 Clinical Trial Data in Moderate-to-Severe Acne"
03/07/2022 8-K Quarterly results
12/01/2021 8-K Completion of Acquisition or Disposition of Assets, Creation of a Direct Financial Obligation or an Obligation under an Off-B...
Docs: "CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY"
11/29/2021 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
11/15/2021 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "AnaptysBio Announces Positive Rosnilimab Healthy Volunteer Phase 1 Top-Line Data"
11/04/2021 8-K Quarterly results
Docs: "AnaptysBio Announces Third Quarter 2021 Financial Results and Provides Pipeline Updates"
10/25/2021 8-K Entry into a Material Definitive Agreement  Interactive Data
10/04/2021 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "AnaptysBio Presents Updated Data From Imsidolimab Phase 2 GALLOP Trial in Generalized Pustular Psoriasis"
08/09/2021 8-K Quarterly results
Docs: "AnaptysBio Announces Second Quarter 2021 Financial Results and Provides Pipeline Updates"
06/17/2021 8-K Quarterly results
06/02/2021 8-K Quarterly results
05/04/2021 8-K Quarterly results
04/12/2021 8-K Quarterly results
03/08/2021 8-K Quarterly results
02/25/2021 8-K Quarterly results
01/19/2021 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "OF THE SECURITIES EXCHANGE ACT OF"
01/11/2021 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy